Treating mice with only αCD38‐tLNPs‐siRNA to silence the expression of CKAP5, successfully reduced the occupancy of MM cells in the BM and lead to an overall decrease in disease burden, therefore indicating their clear antitumoral effects for MM. This evidence concerns the gene CKAP5 and Miyoshi myopathy.